Celularity Inc
CELUNasdaqCIK 1752828HealthcareFiscal year ends Dec 31
Reports and events: 184 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2017:08 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-047787 |
| 2026-10-2009:15 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001493152-26-047708 |
| 2026-09-2917:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-044917 |
| 2026-09-2917:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-044892 |
| 2026-09-2813:14 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-111279 |
| 2026-09-2806:14 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-044421 |
| 2026-09-1409:00 ET | 8-K | 8.01 Other events | 0001493152-26-042495 |
| 2026-08-0717:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-036648 |
| 2026-07-2916:15 ET | 8-K | 3.01 Delisting notice | 0001493152-26-035193 |
| 2026-06-3009:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-031216 |
| 2026-06-2517:27 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-030199 |
| 2026-06-2306:02 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-076580 |
| 2026-06-1217:15 ET | 8-K | 3.01 Delisting notice | 0001493152-26-028519 |
| 2026-06-0317:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027132 |
| 2026-05-2816:54 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-26-025646 |
| 2026-04-3016:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-020424 |
| 2026-04-2210:16 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-046494 |
| 2026-04-2109:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018220 |
| 2026-04-0311:08 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-26-039490 |
| 2026-03-1009:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-009471 |
| 2026-03-0517:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-009017 |
| 2026-01-2116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-003100 |
| 2025-12-3116:15 ET | S-1 | Registration statement | 0001493152-25-029802 |
| 2025-12-2316:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-029033 |
| 2025-12-1916:15 ET | S-1 | Registration statement | 0001493152-25-028562 |
| 2025-12-1916:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-25-028560 |
| 2025-12-0516:30 ET | 8-K | 8.01 Other events | 0001493152-25-026383 |
| 2025-11-1416:09 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-023467 |
| 2025-11-0713:13 ET | DEF 14A | Proxy statementPeriod 2025-11-07 | 0001493152-25-021208 |
| 2025-10-2809:29 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-019839 |
| 2025-09-0317:40 ET | 8-K | 8.01 Other events | 0001641172-25-026245 |
| 2025-08-2917:21 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-026067 |
| 2025-08-2917:17 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-026056 |
| 2025-08-1816:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-024623 |
| 2025-08-1216:59 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-023231 |
| 2025-08-0106:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-021831 |
| 2025-07-3016:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-021556 |
| 2025-07-2916:18 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001641172-25-021378 |
| 2025-07-2821:44 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-25-002573 |
| 2025-07-2216:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-020580 |
| 2025-06-1016:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-014525 |
| 2025-06-0616:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-014073 |
| 2025-05-2117:29 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001641172-25-011942 |
| 2025-05-2016:52 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001641172-25-011751 |
| 2025-05-1616:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-011253 |
| 2025-05-0916:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009462 |
| 2025-05-0817:28 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-009319 |
| 2025-05-0116:15 ET | 8-K | 8.01 Other events | 0001641172-25-008104 |
| 2025-04-2317:15 ET | 8-K | 3.01 Delisting notice | 0001641172-25-005884 |
| 2025-03-2116:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-011156 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 09:26 ET. Listed shows no prices and gives no investment advice.